Provided by Tiger Fintech (Singapore) Pte. Ltd.

Disc Medicine

46.16
+0.74001.63%
Post-market: 46.160.00000.00%16:00 EDT
Volume:301.69K
Turnover:13.95M
Market Cap:1.60B
PE:-11.65
High:47.16
Open:45.82
Low:45.44
Close:45.42
Loading ...

Disc Medicine Highlights 2025 Strategy and Financial Updates

TIPRANKS
·
10 Jan

Disc Medicine outlines recent pipeline, priorities for 2025

TIPRANKS
·
10 Jan

Disc Medicine:Expects to Report Material Weakness in Internal Control Over Financial Reporting in Annual Report on Form 10-K for Yt Ended Dec 31, 2024

THOMSON REUTERS
·
10 Jan

Disc Medicine : Material Weakness Is Related to Lack of Design and Maintenance of Effective Itgc Over Certain Key Financial It Systems

THOMSON REUTERS
·
10 Jan

Disc Medicine Inc: to Date, Co Has Not Identified Any Misstatements in Its Financial Statements

THOMSON REUTERS
·
10 Jan

Disc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025

GlobeNewswire
·
10 Jan

Stifel Nicolaus Reaffirms Their Buy Rating on Disc Medicine (IRON)

TIPRANKS
·
10 Dec 2024

Disc Medicine (IRON) Gets a Buy from Wells Fargo

TIPRANKS
·
10 Dec 2024

Disc Medicine Presents Data Showing Potential Benefits of 3 Investigational Drugs

MT Newswires Live
·
10 Dec 2024

Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

GlobeNewswire
·
10 Dec 2024

Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX), UnitedHealth (UNH) and Disc Medicine (IRON)

TIPRANKS
·
09 Dec 2024

Scotiabank Remains a Buy on Disc Medicine (IRON)

TIPRANKS
·
09 Dec 2024

Promising Prospects for Disc Medicine’s DISC-0974: Strong Efficacy in Myelofibrosis-Related Anemia Warrants Buy Rating

TIPRANKS
·
09 Dec 2024

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Disc Medicine (IRON) and BridgeBio Pharma (BBIO)

TIPRANKS
·
09 Dec 2024

Disc Medicine Price Target Maintained With a $118.00/Share by HC Wainwright & Co.

Dow Jones
·
09 Dec 2024

Douglas Tsao’s Buy Rating for Disc Medicine: Promising Efficacy and Market Potential of DISC-0974 in Anemia Treatment

TIPRANKS
·
09 Dec 2024

BRIEF-Disc Medicine Presents Positive Updated Results From Phase 1B Trial In Patients With Myelofibrosis (MF) And Anemia

Reuters
·
09 Dec 2024

Disc Medicine Presents Positive Updated Results From Phase 1B Trial in Patients With Myelofibrosis (Mf) and Anemia in an Oral Presentation at the 66TH American Society of Hematology (Ash) Annual Meeting

THOMSON REUTERS
·
09 Dec 2024

Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting

GlobeNewswire
·
09 Dec 2024

Press Release: LABRADOR IRON ORE ROYALTY CORPORATION - IRON ORE COMPANY OF CANADA DIVIDEND

Dow Jones
·
28 Nov 2024